Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jost

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Cell Death & Disease|January 25, 2020
Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Cell Death and Differentiation|June 3, 2021
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSFXin Wang, Uris Ros, Deepti Agrawal, et al.
Frontiers in Oncology|May 23, 2022
The Impact of Postoperative Tumor Burden on Patients With Brain MetastasesAmir Kaywan Aftahy, Melanie Barz, Nicole Lange, et al.
Cell Death and Differentiation|July 1, 2021
Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSFXin Wang, Uris Ros, Deepti Agrawal, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysisMoritz Müller, Florian Posch, Dominik Kiem, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Journal of Thrombosis and Haemostasis : JTH|February 16, 2025
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortalityFlorian Moik, Angelika Terbuch, Ariane Sprakel, et al.
Cell Death & Disease|January 25, 2020
Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAPJanin Knop, Lisanne M Spilgies, Stefanie Rufli, et al.
Oncogene|January 29, 2022
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent mannerAnna-Lena Meinhardt, Enkhtsetseg Munkhbaatar, Ulrike Höckendorf, et al.
Cell Death and Differentiation|June 3, 2021
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSFXin Wang, Uris Ros, Deepti Agrawal, et al.
Frontiers in Oncology|May 23, 2022
The Impact of Postoperative Tumor Burden on Patients With Brain MetastasesAmir Kaywan Aftahy, Melanie Barz, Nicole Lange, et al.
Cell Death and Differentiation|July 1, 2021
Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSFXin Wang, Uris Ros, Deepti Agrawal, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysisMoritz Müller, Florian Posch, Dominik Kiem, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Pageof 21